๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This is a multicenter, phase 2, open label study to evaluate safety, tolera...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2025-09-05
Trial ID
NCT07102901
Treatments Being Tested
This is a Phase 1 multicenter, single-arm, open-label, dose escalation and ...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital, Peking University
Start Date
2018-08-14
Trial ID
NCT03603951
Treatments Being Tested
The study aimed to assess the effects of omeprazole on single-dose SHR2554 ...
Status
Completed
Location
The Second Affiliated Hospital of Zhejiang University School of Medicine
Start Date
2023-11-06
Trial ID
NCT06093945
Treatments Being Tested
The primary objective of the study is to evaluate the effect of high-fat di...
Status
Completed
Location
Henan Cancer Hospital
Start Date
2019-08-06
Trial ID
NCT04335266
Treatments Being Tested
Evaluate the safety, tolerability, and objective response rate (ORR) of SHR...
Status
Recruiting
Location
Sun Yat-sen University Cancer Center
Start Date
2025-10-09
Trial ID
NCT07175220
Treatments Being Tested
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
This study was designed as a prospective, multicenter, open-label, randomiz...
Status
Not Yet Recruiting
Location
The First Affiliated Hospital of Soochow University
Start Date
2026-06
Trial ID
NCT07575412
Treatments Being Tested
The primary objective of the study is to evaluate the effect of Rifampin on...
Status
Completed
Location
Jiangsu HengRui Medicine Co., Ltd.
Start Date
2020-05-28
Trial ID
NCT04577885
Treatments Being Tested
Immunotherapy combined with chemotherapy has become the standard first-line...
Status
Recruiting
Location
The First Affiliated Hospital of Zhengzhou University
Start Date
2025-06-15
Trial ID
NCT07294664
The aim of this trial is to study the tolerance, pharmacokinetics (PK) and ...
Status
Terminated
Location
Fudan University Shanghai Cancer Center
Start Date
2018-11-20
Trial ID
NCT03741712